Eric J Miller

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Emergency Department

Replacement Therapy

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Eric J Miller, Tracy L Rose, Benjamin L Maughan, Matthew I Milowsky, Mehmet Asim Bilen, Bradley C Carthon, Xin Gao, Suthee Rapisuwon, Qianqian Zhao, Menggang Yu, Neeraj Agarwal, Matthew D Galsky
Phase 2 trial of tremelimumab in patients with metastatic urothelial cancer previously treated with programmed death 1/programmed death ligand 1 blockade. Cancer (2024)
Eric J Miller, Tracy L Rose, Benjamin L Maughan, Matthew I Milowsky, Mehmet Asim Bilen, Bradley C Carthon, Xin Gao, Suthee Rapisuwon, Qianqian Zhao, Menggang Yu, Neeraj Agarwal, Matthew D Galsky
Phase 2 trial of tremelimumab in patients with metastatic urothelial cancer previously treated with programmed death 1/programmed death ligand 1 blockade. Cancer 130 (9) (2024)
Eric J Miller, Tracy L Rose, Benjamin L Maughan, Matthew I Milowsky, Mehmet Asim Bilen, Bradley C Carthon, Xin Gao, Suthee Rapisuwon, Qianqian Zhao, Menggang Yu, Neeraj Agarwal, Matthew D Galsky
Phase 2 trial of tremelimumab in patients with metastatic urothelial cancer previously treated with programmed death 1/programmed death ligand 1 blockade. Cancer 130 (9) (2024)
Eric J Miller, Tracy L Rose, Benjamin L Maughan, Matthew I Milowsky, Mehmet Asim Bilen, Bradley C Carthon, Xin Gao, Suthee Rapisuwon, Qianqian Zhao, Menggang Yu, Neeraj Agarwal, Matthew D Galsky
Phase 2 trial of tremelimumab in patients with metastatic urothelial cancer previously treated with programmed death 1/programmed death ligand 1 blockade. Cancer 130 (9) (2024)